Long-term outcomes of Graves' disease in children and adolescents receiving antithyroid drugs
Purpose Antithyroid drugs (ATDs) are primarily used as an initial treatment in pediatric patients with Graves' disease (GD). We aimed to investigate the long-term outcomes in pediatric GD patients receiving ATDs. Methods Retrospective data from a single center were collected from April 2003 to...
Saved in:
Main Authors: | Jung Gi Rho (Author), Change Dae Kum (Author), Young Jun Seo (Author), Young Suk Shim (Author), Hae Sang Lee (Author), Jin Soon Hwang (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pediatric Endocrinology,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary on "Long-term outcomes of Graves' disease in children and adolescents receiving antithyroid drugs"
by: Minsun Kim
Published: (2021) -
Comparison of the clinical characteristics and outcomes of pediatric patients with and without diabetic ketoacidosis at the time of type 1 diabetes diagnosis
by: Young-Jun Seo, et al.
Published: (2022) -
Effects of methimazole, an antithyroid drug, on the patients with graves' disease
by: Chitvimol Pavitrapok
Published: (2014) -
Effectiveness of growth hormone therapy in children with Noonan syndrome
by: Eun mi Seok, et al.
Published: (2020) -
Predicting remission of Graves' disease following treatment with antithyroid drugs
by: Natalya V. Drogashevskaya, et al.
Published: (2023)